These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38369337)

  • 21. Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.
    Hirose S; Murakami N; Takahashi K; Kuno I; Takayanagi D; Asami Y; Matsuda M; Shimada Y; Yamano S; Sunami K; Yoshida K; Honda T; Nakahara T; Watanabe T; Komatsu M; Hamamoto R; Kato MK; Matsumoto K; Okuma K; Kuroda T; Okamoto A; Itami J; Kohno T; Kato T; Shiraishi K; Yoshida H
    Gynecol Oncol; 2020 Jan; 156(1):203-210. PubMed ID: 31757465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological characteristics of patients with mucinous adenocarcinoma of the uterine cervix: A retrospective study of 21 cases.
    Bonin L; Devouassoux-Shisheboran M; Golfier F
    J Gynecol Obstet Hum Reprod; 2019 May; 48(5):319-327. PubMed ID: 30807852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Histopathological Risk Factors on the Treatment of Stage IB-IIB Uterine Cervical Cancer.
    Shimada M; Tokunaga H; Kigawa J; Yaegashi N
    Tohoku J Exp Med; 2020 Dec; 252(4):339-351. PubMed ID: 33311005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
    Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM
    Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive molecular profiling broadens treatment options for breast cancer patients.
    Kawaji H; Kubo M; Yamashita N; Yamamoto H; Kai M; Kajihara A; Yamada M; Kurata K; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Mori H; Akiyoshi S; Oki E; Oda Y; Baba E; Mori M; Nakamura M
    Cancer Med; 2021 Jan; 10(2):529-539. PubMed ID: 33274848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
    Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
    Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucinous adenocarcinoma, gastric type of the uterine cervix: clinical features and HER2 amplification.
    Nakamura A; Yamaguchi K; Minamiguchi S; Murakami R; Abiko K; Hamanishi J; Kondoh E; Baba T; Mandai M; Matsumura N
    Med Mol Morphol; 2019 Mar; 52(1):52-59. PubMed ID: 29992451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
    La Fleur L; Falk-Sörqvist E; Smeds P; Berglund A; Sundström M; Mattsson JS; Brandén E; Koyi H; Isaksson J; Brunnström H; Nilsson M; Micke P; Moens L; Botling J
    Lung Cancer; 2019 Apr; 130():50-58. PubMed ID: 30885352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastric-type mucinous carcinoma of the cervix and its precursors - historical overview.
    Mikami Y
    Histopathology; 2020 Jan; 76(1):102-111. PubMed ID: 31846534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
    Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
    Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component.
    Li X; Sun K; Liao X; Gao H; Zhu H; Xu R
    BMC Cancer; 2020 May; 20(1):400. PubMed ID: 32384877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma.
    Basturk O; Berger MF; Yamaguchi H; Adsay V; Askan G; Bhanot UK; Zehir A; Carneiro F; Hong SM; Zamboni G; Dikoglu E; Jobanputra V; Wrzeszczynski KO; Balci S; Allen P; Ikari N; Takeuchi S; Akagawa H; Kanno A; Shimosegawa T; Morikawa T; Motoi F; Unno M; Higuchi R; Yamamoto M; Shimizu K; Furukawa T; Klimstra DS
    Mod Pathol; 2017 Dec; 30(12):1760-1772. PubMed ID: 28776573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats.
    Movassaghi M; Shabihkhani M; Hojat SA; Williams RR; Chung LK; Im K; Lucey GM; Wei B; Mareninov S; Wang MW; Ng DW; Tashjian RS; Magaki S; Perez-Rosendahl M; Yang I; Khanlou N; Vinters HV; Liau LM; Nghiemphu PL; Lai A; Cloughesy TF; Yong WH
    Exp Mol Pathol; 2017 Aug; 103(1):87-93. PubMed ID: 28663030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
    Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W
    Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptome profiling of gastric-type endocervical adenocarcinomas identifies key signaling pathways for tumor progression.
    Vasseur D; Lopez J; Croce S; Tondeur G; Bonin L; Descotes F; Golfier F; Devouassoux-Shisheboran M
    Gynecol Oncol; 2020 Jun; 157(3):775-782. PubMed ID: 32317172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Focus on mucinous adenocarcinoma of the uterine cervix].
    Bonin L; Devouassoux-Shisheboran M; Golfier F
    Gynecol Obstet Fertil Senol; 2019 Apr; 47(4):352-361. PubMed ID: 30771514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stromal p16 Overexpression in Gastric-type Mucinous Carcinoma of the Uterine Cervix.
    Chung T; DO SI; Na K; Kim G; Jeong YI; Kim YW; Kim HS
    Anticancer Res; 2018 Jun; 38(6):3551-3558. PubMed ID: 29848709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Profiling of Appendiceal Adenocarcinoma and Comparison with Right-sided and Left-sided Colorectal Cancer.
    Tokunaga R; Xiu J; Johnston C; Goldberg RM; Philip PA; Seeber A; Naseem M; Lo JH; Arai H; Battaglin F; Puccini A; Berger MD; Soni S; Zhang W; Hwang JJ; Shields AF; Marshall JL; Baba H; Korn WM; Lenz HJ
    Clin Cancer Res; 2019 May; 25(10):3096-3103. PubMed ID: 30692096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.
    Qian ZR; Rubinson DA; Nowak JA; Morales-Oyarvide V; Dunne RF; Kozak MM; Welch MW; Brais LK; Da Silva A; Li T; Li W; Masuda A; Yang J; Shi Y; Gu M; Masugi Y; Bui J; Zellers CL; Yuan C; Babic A; Khalaf N; Aguirre A; Ng K; Miksad RA; Bullock AJ; Chang DT; Tseng JF; Clancy TE; Linehan DC; Findeis-Hosey JJ; Doyle LA; Thorner AR; Ducar M; Wollison B; Laing A; Hahn WC; Meyerson M; Fuchs CS; Ogino S; Hornick JL; Hezel AF; Koong AC; Wolpin BM
    JAMA Oncol; 2018 Mar; 4(3):e173420. PubMed ID: 29098284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cancer.
    Yokose T; Kitago M; Matsuda S; Sasaki Y; Masugi Y; Nakamura Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Yusuke F; Nakano Y; Endo Y; Abe K; Tokino T; Kitagawa Y
    Cancer Sci; 2020 Jun; 111(6):2174-2182. PubMed ID: 32314446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.